P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL

oleh: Nigel Russell, Oliver Cumming, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Jelena Jovanovic, Amanda Gilkes, Leona Batten, Joanna Canham, Emily Laura Hinson, Panagiotis Kottaridis, Jamie Cavenagh, Claire Arnold, Mike Dennis, Steven Knapper